glp 1 and colon cancer GLP-1s show 'mind-blowing' effect on colorectal risk Does GLP-1 Cause Colon Cancer?

The scale only tells part of the story

However, the significantly greater weight reduction associated with GLP-1 based therapies and their proven health benefits (e.g., reduction in cardiovascular disease with semaglutide [29] and improved sleep apnea with tirzepatide [30]), as well as a wider acceptance that medication is needed for sustained weight reduction success, has triggered a rapid surge in their uptake [31]

She mentioned phentermine/topiramate (Qsymia), which can aid weight loss but may bring mood changes, anxiety, or sleep issues, and naltrexone/bupropion (Contrave), which can help but may raise blood pressure and isn't safe for people on opioids

(2010, June 1)

22,23 In the liver, GLP-1RAs can also decrease hepatic gluconeogenesis and enhance glucose uptake, which can improve circulating glucose levels

Retatrutide, a triple-hormone agonist, has been shown in Phase 2 trials to be extremely effective in inducing weight loss in a dose-dependent manner.42 Given the potential extraordinary economic and composite health benefits to the individual and population, it seems likely that the area of Bariatric Pharmacology will continue to expand